3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
4
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
5
Whole-Body Irradiation
4
Busulfan
4
Biopsy
4
Specimen Handling
3
Injections
3
Cytarabine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
Azacitidine
2
treosulfan
1
peginterferon alfa-2b
1
olutasidenib
1
itacitinib
1
canakinumab
1
aldesleukin
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Early Intervention, Educational
×
30 days
×
Clear all
No trials found.